Stayble Therapeutics visited the Bio International Convention in Boston
As part of Stayble Therapeutics’ (“Stayble”) strategy to find a development partner, the company participated in the international Bio International Convention in Boston last week. During the convention, Stayble presented to several potential partners who could bring Stayble's drug candidate to the market.For four days, June 5-8, Stayble's CEO Andreas Gerward and COO Mattias Münnich attended the Bio International Convention to network and present Stayble's drug candidate. The purpose of Stayble's participation was to follow up on existing contacts and identify additional interesting